Clinical Trials Directory

Trials / Completed

CompletedNCT03703544

The Glycaemic Response of Local Foods Using the Continuous Glucose Monitoring System

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Singapore Institute of Food and Biotechnology Innovation · Other Government
Sex
Male
Age
21 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study is carried out to determine the effect of high and low GI of local foods using Continuous Glucose Monitoring System (CGMS™) on 24 hour blood glucose profiles.

Detailed description

Glycemic Index (GI) is a method of classifying foods based on the food's ability to raise the blood glucose level. Low GI foods are recommended as Participants will have a lower impact on blood glucose concentrations. The research sets out to determine the effect of GI on 24 hour blood glucose profiles in healthy Chinese male participants. There will be two test sessions where participants will consume either a high or low GI breakfast, lunch, snack and dinner. Participants will take part in two test sessions (each spanning over 3 days and to monitor the participants' glycemic response using a Continuous Glucose Monitoring System (CGMS) throughout the period.This study specifically attempts to see how having high and low GI locally consumed meals impact on blood glucose.

Conditions

Interventions

TypeNameDescription
OTHERHigh glycemic indexWheat yellow noodle, glutinous rice, tea with sucrose, biscuits, jelly made with sucrose and teriyaki chicken rice.The foods provided have been tested as high glycemic index. Participants' blood glucose will be monitored using the Continuous Glucose Monitor.
OTHERLow glycemic indexBeta-glucan yellow noodle, basmati rice, tea with isomaltulose, biscuits, jelly made with isomaltulose and mung bean noodles.The foods provided have been tested as low glycemic index.Participants' blood glucose will be monitored using the Continuous Glucose Monitor.

Timeline

Start date
2017-12-15
Primary completion
2020-05-22
Completion
2020-05-22
First posted
2018-10-12
Last updated
2020-07-17

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT03703544. Inclusion in this directory is not an endorsement.